Inhalation and Nasal Spray Generic Drugs Market size is expected to grow at a CAGR of 4.83% during the forecast period and the market size is expected to reach nearly US$ 46.20 Bn. by 2029.To know about the Research Methodology :- Request Free Sample Report Inhalation and Nasal Spray Generic Drugs Market Drivers and Restrains: Inhalation and nasal spray products usually include a delivery device. An inhaler and nasal is a medical device used for delivering medication into the body via the lungs and insufflated through the nose. The inhalation and nasal spray generic drugs market has driven by factors like low cost involved with generic prescription drugs, rising geriatric population, increasing number of generic, rise in incidence of asthma, COPD, and other respiratory diseases. The incredibly high healthcare costs in the developed economies are driving the growing patient pool towards generic drugs. However, stringent regulatory policies for generic drugs in developing countries are restraining the market growth at the global level. Patent expiry of blockbuster drugs would provide new opportunities for generic drug manufacturers in the inhalation and nasal spray generic drugs market.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.
Inhalation and Nasal Spray Generic Drugs Market Segment Analysis:
Based on the drug class, the inhalation and nasal spray generic drugs market has been segmented into bronchodilators, corticosteroids, decongestant sprays, antihistamines, and combinations. The combinations spays segment held the dominant share of xx% for the inhalation and nasal spray generic drugs market in 2022, and is anticipated to grow at the largest CAGR of xx% during the forecast period. This drug class confirms increased efficiency and better compliance to pharmaceutical regulations, due to which it witnesses a high demand globally.Inhalation and Nasal Spray Generic Drugs Market Regional Insights:
Region-wise, the inhalation and nasal spray generic drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe held the largest market share in 2022 due to the high level of patient safety and care protocols maintained in the region through the imposition of very strict government regulations. The high prevalence of diseases and well-established health care infrastructure that enables proper diagnosis of diseases such as asthma and COPD will drive regional market growth. The market in Asia Pacific is expected to expand at a high CAGR of xx% during the forecast period due to a rapidly evolving healthcare industry, coupled with the highest population density in the world, the increasing patient pool for COPD and asthma.Inhalation and Nasal Spray Generic Drugs Market Competitive landscape Major Key players operating in this market are Nephron Pharmaceuticals Corporation, Allergan plc, Roxane Laboratories, Inc., Ranbaxy Laboratories Ltd., Beximco Pharmaceuticals. Manufacturers in the inhalation and nasal spray generic drugs are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers. The objective of the report is to present comprehensive analysis of inhalation and nasal spray generic drugs market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding inhalation and nasal spray generic drugs market dynamics, structure by analyzing the market segments, and project the inhalation and nasal spray generic drugs market size. Clear representation of competitive analysis of key players by product type, price, financial position, product portfolio, growth strategies, and regional presence in the inhalation and nasal spray generic drugs market make the report investor’s guide.Inhalation and Nasal Spray Generic Drugs Market Scope: Inquiry Before Buying
Global Inhalation and Nasal Spray Generic Drugs Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 33.21 Bn. Forecast Period 2023 to 2029 CAGR: 4.83% Market Size in 2029: US $ 46.20 Bn. Segments Covered: by Product type Corticosteroids Bronchodilators Combinations Decongestant Sprays by Application Asthma COPD Allergic Rhinitis Other Respiratory Disorders Inhalation and Nasal Spray Generic Drugs Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Inhalation and Nasal Spray Generic Drugs Market, Key Players:
1. Nephron Pharmaceuticals Corporation 2. Allergan plc 3. Roxane Laboratories, Inc. 4. Ranbaxy Laboratories Ltd. 5. Beximco Pharmaceuticals 6. Mylan N.V. 7. Cipla Ltd. 8. Teva Pharmaceutical 9. Apotex 10.Sun Pharma 11.Hikma Pharma 12.XIANJU PHARMA 13.Astra Zenaca 14.Nippon Shinyaku Co., Ltd. 15.Acerus Pharmaceuticals 16.Akorn 17.Hikma 18.Sandoz 19.Perrigo Company plc, Cipla Ltd. 20.Viatris Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Inhalation and Nasal Spray Generic Drugs Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Inhalation and Nasal Spray Generic Drugs Market? Ans: The Global Inhalation and Nasal Spray Generic Drugs Market is growing at a CAGR of 4.83% during forecasting period 2023-2029. 3. What is scope of the Global Inhalation and Nasal Spray Generic Drugs market report? Ans: Global Inhalation and Nasal Spray Generic Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Inhalation and Nasal Spray Generic Drugs market? Ans: The important key players in the Global Inhalation and Nasal Spray Generic Drugs Market are – Nephron Pharmaceuticals Corporation, Allergan plc, Roxane Laboratories, Inc., Ranbaxy Laboratories Ltd., Beximco Pharmaceuticals, Mylan N.V., Cipla Ltd., Teva Pharmaceutical, Apotex, Sun Pharma, Hikma Pharma, XIANJU PHARMA, Astra Zenaca, Nippon Shinyaku Co., Ltd., Acerus Pharmaceuticals, Akorn, Hikma, Sandoz, Perrigo Company plc, Cipla Ltd., and Viatris Inc. 5. What is the study period of this market? Ans: The Global Inhalation and Nasal Spray Generic Drugs Market is studied from 2022 to 2029.
1. Inhalation and Nasal Spray Generic Drugs Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Inhalation and Nasal Spray Generic Drugs Market: Dynamics 2.1. Inhalation and Nasal Spray Generic Drugs Market Trends by Region 2.1.1. North America Inhalation and Nasal Spray Generic Drugs Market Trends 2.1.2. Europe Inhalation and Nasal Spray Generic Drugs Market Trends 2.1.3. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Trends 2.1.4. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Trends 2.1.5. South America Inhalation and Nasal Spray Generic Drugs Market Trends 2.2. Inhalation and Nasal Spray Generic Drugs Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Inhalation and Nasal Spray Generic Drugs Market Drivers 2.2.1.2. North America Inhalation and Nasal Spray Generic Drugs Market Restraints 2.2.1.3. North America Inhalation and Nasal Spray Generic Drugs Market Opportunities 2.2.1.4. North America Inhalation and Nasal Spray Generic Drugs Market Challenges 2.2.2. Europe 2.2.2.1. Europe Inhalation and Nasal Spray Generic Drugs Market Drivers 2.2.2.2. Europe Inhalation and Nasal Spray Generic Drugs Market Restraints 2.2.2.3. Europe Inhalation and Nasal Spray Generic Drugs Market Opportunities 2.2.2.4. Europe Inhalation and Nasal Spray Generic Drugs Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Drivers 2.2.3.2. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Restraints 2.2.3.3. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Opportunities 2.2.3.4. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Drivers 2.2.4.2. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Restraints 2.2.4.3. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Opportunities 2.2.4.4. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Challenges 2.2.5. South America 2.2.5.1. South America Inhalation and Nasal Spray Generic Drugs Market Drivers 2.2.5.2. South America Inhalation and Nasal Spray Generic Drugs Market Restraints 2.2.5.3. South America Inhalation and Nasal Spray Generic Drugs Market Opportunities 2.2.5.4. South America Inhalation and Nasal Spray Generic Drugs Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Inhalation and Nasal Spray Generic Drugs Industry 2.8. Analysis of Government Schemes and Initiatives For Inhalation and Nasal Spray Generic Drugs Industry 2.9. Inhalation and Nasal Spray Generic Drugs Market Trade Analysis 2.10. The Global Pandemic Impact on Inhalation and Nasal Spray Generic Drugs Market 3. Inhalation and Nasal Spray Generic Drugs Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 3.1.1. Corticosteroids 3.1.2. Bronchodilators 3.1.3. Combinations 3.1.4. Decongestant Sprays 3.2. Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 3.2.1. Asthma 3.2.2. COPD 3.2.3. Allergic Rhinitis 3.2.4. Other Respiratory Disorders 3.3. Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Region (2022-2029) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 4.1.1. Corticosteroids 4.1.2. Bronchodilators 4.1.3. Combinations 4.1.4. Decongestant Sprays 4.2. North America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 4.2.1. Asthma 4.2.2. COPD 4.2.3. Allergic Rhinitis 4.2.4. Other Respiratory Disorders 4.3. North America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Country (2022-2029) 4.3.1. United States 4.3.1.1. United States Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 4.3.1.1.1. Corticosteroids 4.3.1.1.2. Bronchodilators 4.3.1.1.3. Combinations 4.3.1.1.4. Decongestant Sprays 4.3.1.2. United States Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 4.3.1.2.1. Asthma 4.3.1.2.2. COPD 4.3.1.2.3. Allergic Rhinitis 4.3.1.2.4. Other Respiratory Disorders 4.3.2. Canada 4.3.2.1. Canada Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 4.3.2.1.1. Corticosteroids 4.3.2.1.2. Bronchodilators 4.3.2.1.3. Combinations 4.3.2.1.4. Decongestant Sprays 4.3.2.2. Canada Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 4.3.2.2.1. Asthma 4.3.2.2.2. COPD 4.3.2.2.3. Allergic Rhinitis 4.3.2.2.4. Other Respiratory Disorders 4.3.3. Mexico 4.3.3.1. Mexico Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 4.3.3.1.1. Corticosteroids 4.3.3.1.2. Bronchodilators 4.3.3.1.3. Combinations 4.3.3.1.4. Decongestant Sprays 4.3.3.2. Mexico Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 4.3.3.2.1. Asthma 4.3.3.2.2. COPD 4.3.3.2.3. Allergic Rhinitis 4.3.3.2.4. Other Respiratory Disorders 5. Europe Inhalation and Nasal Spray Generic Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.2. Europe Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3. Europe Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Country (2022-2029) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.1.2. United Kingdom Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.2. France 5.3.2.1. France Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.2.2. France Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.3. Germany 5.3.3.1. Germany Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.3.2. Germany Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.4. Italy 5.3.4.1. Italy Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.4.2. Italy Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.5. Spain 5.3.5.1. Spain Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.5.2. Spain Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.6. Sweden 5.3.6.1. Sweden Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.6.2. Sweden Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.7. Austria 5.3.7.1. Austria Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.7.2. Austria Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 5.3.8.2. Rest of Europe Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.2. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Country (2022-2029) 6.3.1. China 6.3.1.1. China Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.1.2. China Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.2. S Korea 6.3.2.1. S Korea Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.2.2. S Korea Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.3. Japan 6.3.3.1. Japan Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.3.2. Japan Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.4. India 6.3.4.1. India Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.4.2. India Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.5. Australia 6.3.5.1. Australia Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.5.2. Australia Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.6. Indonesia 6.3.6.1. Indonesia Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.6.2. Indonesia Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.7. Malaysia 6.3.7.1. Malaysia Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.7.2. Malaysia Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.8. Vietnam 6.3.8.1. Vietnam Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.8.2. Vietnam Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.9. Taiwan 6.3.9.1. Taiwan Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.9.2. Taiwan Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 6.3.10.2. Rest of Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 7. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 7.2. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 7.3. Middle East and Africa Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Country (2022-2029) 7.3.1. South Africa 7.3.1.1. South Africa Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 7.3.1.2. South Africa Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 7.3.2. GCC 7.3.2.1. GCC Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 7.3.2.2. GCC Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 7.3.3. Nigeria 7.3.3.1. Nigeria Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 7.3.3.2. Nigeria Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 7.3.4.2. Rest of ME&A Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 8. South America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 8.2. South America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 8.3. South America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Country (2022-2029) 8.3.1. Brazil 8.3.1.1. Brazil Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 8.3.1.2. Brazil Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 8.3.2. Argentina 8.3.2.1. Argentina Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 8.3.2.2. Argentina Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Product type (2022-2029) 8.3.3.2. Rest Of South America Inhalation and Nasal Spray Generic Drugs Market Size and Forecast, by Application (2022-2029) 9. Global Inhalation and Nasal Spray Generic Drugs Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Inhalation and Nasal Spray Generic Drugs Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Nephron Pharmaceuticals Corporation 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Allergan plc 10.3. Roxane Laboratories, Inc. 10.4. Ranbaxy Laboratories Ltd. 10.5. Beximco Pharmaceuticals 10.6. Mylan N.V. 10.7. Cipla Ltd. 10.8. Teva Pharmaceutical 10.9. Apotex 10.10. Sun Pharma 10.11. Hikma Pharma 10.12. XIANJU PHARMA 10.13. Astra Zenaca 10.14. Nippon Shinyaku Co., Ltd. 10.15. Acerus Pharmaceuticals 10.16. Akorn 10.17. Hikma 10.18. Sandoz 10.19. Perrigo Company plc, Cipla Ltd. 10.20. Viatris Inc. 11. Key Findings 12. Industry Recommendations 13. Inhalation and Nasal Spray Generic Drugs Market: Research Methodology 14. Terms and Glossary